Cytodyn Inc (CYDY)

[misiu143]

I like your post.... Some longs here what I see , sold their shares for higher price , and now waiting / working hard to see 0.70 to buy back.
You are right , lot depend what will happen with P 3 adjunct.
In few weeks company will be meeting face to face with FDA , asking to decrease # of patient needed for this study again.
We need now 150 patients for p 3 adjunct , and TaiMed need 30 for IV p 3 treatment.
This don't look fair to me , but of course I am not FDA...))
I feel that CYDY might receive improvement on this.
Another thing during last CC Dr P said that with the patients they have by now on P3 adjunct , they feel that they met FDA requirement for Breakthrough Designation and they will ask for it.
Let's see , in the next few weeks , many things may change for better for CYDY.